Immediate dilation of a tight or stenotic cervix by intra-procedural administration of hyoscine butylbromide: A clinical trial

Abstract

Background: Cervical dilation is indicated prior to performing various gynecological procedures. However, gynecologists are at times confronted with a stenotic or tight cervix, resistant to dilation. This can be problematic particularly when cervical ripening has not been attempted hours before the start of the procedure.


Objective: The objective of this study is to investigate the efficacy of administration of hyoscine butylbromide for cervical dilation for immediate dilation of the tight or stenotic cervix.


Materials and Methods: In this clinical trial study, a population of 40 women, aged 20-70 yr with stenotic cervix, evidenced by resistance to pass dilator #2 through their cervical canal were compared. Cervical patency was assessed 10 min following intracervical canal instillation of hyoscine butylbromide.


Results: Cervical width of 57.5% of patients became wider, as evidenced by passage of the number 4 Hegar dilator through the cervical canal without resistance. Independent T-tests did not reveal any statistically significant difference between the two groups based on their age. Fisher Exact test revealed a statistically significant difference between the two groups based on the prior route of delivery, with a more statistically significant response in patients who had vaginal deliveries.


Conclusion: Intra-cervical canal instillation of hyoscine butylbromide is effective in immediate dilation of the tight or stenotic cervix during intra-uterine procedures.

References
[1] Gelber S, Sciscione A. Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol 2006;
49: 642–657.

[2] Bradley LD. Complications in hysteroscopy: prevention, treatment, and legal risk. Curr Opin Obstet Gynecol 2002;14: 409–415.

[3] Mohammadian S, Tavana A, Tavana S, Mohammadian A, Fallahian M. Cervical priming by misoprostol before
diagnostic dilatation and curettage: A randomized clinical trial. J Reprod Infertil 2015; 16: 162–166.

[4] Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab 2010; 21: 353–361.

[5] Sirohiwal D, Dahiya K, De M. Efficacy of hyoscine-Nbutyl bromide (Buscopan) suppositories as a cervical
spasmolytic agent in labour. Aust NZ J Obstet Gynaecol 2005; 45: 128–129.

[6] Hadadian S, Fallahian M. Assessing the efficacy of vaginal hyoscine butyl bromide on cervical ripening prior to
intrauterine procedures: A double-blinded clinical trial. Int J Reprod Biomed 2016; 14: 709–712.

[7] Samuels LA, Christie L, Roberts-Gittens B, Fletcher H, Frederick J. The effect of hyoscine butylbromide on the
first stage of labour in term pregnancies. BJOG 2007; 114: 1542–1546.

[8] Hotwani J, Ainapure SS. Hyoscine Butylbromide suppositories. Indian Med Gaz 2000; 217–219.

[9] Qahtani NH, Hajeri FA. The effect of hyoscine butylbromide in shortening the first stage of labor: a double blind,randomized, controlled, clinical trial. Ther Clin Risk Manag2011; 7: 495–500.